SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:
Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AEROB) today announced that they have strengthened their medical team by adding former Teva R&D VP, Dr. Paul Dorinsky. Paul joins Aerocrine as medical director, North America.
Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AEROB) today announced that they have strengthened their medical team by adding former Teva R&D VP, Dr. Paul Dorinsky. Paul joins Aerocrine as medical director, North America.
